- •Preface and Acknowledgments
- •Contents
- •Contributors
- •1: Embryology for Urologists
- •Introduction
- •Renal Development
- •Pronephros
- •Mesonephros
- •Metanephros
- •Development of the Collecting System
- •Critical Steps in Further Development
- •Anomalies of the Kidney
- •Renal Agenesis
- •Renal Aplasia
- •Renal Hypoplasia
- •Renal Ectopia
- •Renal Fusion
- •Ureteral Development
- •Anomalies of Origin
- •Anomalies of Number
- •Incomplete Ureteral Duplication
- •Complete Ureteral Duplication
- •Ureteral Ectopia
- •Embryology of Ectopia
- •Clinical Correlation
- •Location of Ectopic Ureteral Orifices – Male (in Descending Order According to Incidence)
- •Symptoms
- •Ureteroceles
- •Congenital Ureteral Obstruction
- •Pipestem Ureter
- •Megaureter-Megacystis Syndrome
- •Prune Belly Syndrome
- •Vascular Ureteral Obstructions
- •Division of the Urogenital Sinus
- •Bladder Development
- •Urachal Anomalies
- •Cloacal Duct Anomalies
- •Other Bladder Anomalies
- •Bladder Diverticula
- •Bladder Extrophy
- •Gonadal Development
- •Testicular Differentiation
- •Ovarian Differentiation
- •Gonadal Anomalies
- •Genital Duct System
- •Disorders of Testicular Function
- •Female Ductal Development
- •Prostatic Urethral Valves
- •Gonadal Duct Anomalies
- •External Genital Development
- •Male External Genital Development
- •Female External Genital Development
- •Anomalies of the External Genitalia
- •References
- •2: Gross and Laparoscopic Anatomy of the Upper Urinary Tract and Retroperitoneum
- •Overview
- •The Kidneys
- •The Renal Vasculature
- •The Renal Collecting System
- •The Ureters
- •Retroperitoneal Lymphatics
- •Retroperitoneal Nerves
- •The Adrenal Glands
- •References
- •3: Gross and Laparoscopic Anatomy of the Lower Urinary Tract and Pelvis
- •Introduction
- •Female Pelvis
- •Male Pelvis
- •Pelvic Floor
- •Urinary Bladder
- •Urethra
- •Male Urethra
- •Female Urethra
- •Sphincter Mechanisms
- •The Bladder Neck Component
- •The Urethral Wall Component
- •The External Urethral Sphincter
- •Summary
- •References
- •4: Anatomy of the Male Reproductive System
- •Testis and Scrotum
- •Spermatogenesis
- •Hormonal Regulation of Spermatogenesis
- •Genetic Regulation of Spermatogenesis
- •Epididymis and Ductus Deferens
- •Accessory Sex Glands
- •Prostate
- •Seminal Vesicles
- •Bulbourethral Glands
- •Penis
- •Erection and Ejaculation
- •References
- •5: Imaging of the Upper Tracts
- •Anatomy of the Upper Tracts and Introduction to Imaging Modalities
- •Introduction
- •Renal Upper Tract Basic Anatomy
- •Modalities Used for Imaging the Upper Tracts
- •Ultrasound
- •Radiation Issues
- •Contrast Issues
- •Renal and Upper Tract Tumors
- •Benign Renal Tumors
- •Transitional Cell Carcinoma
- •Renal Mass Biopsy
- •Renal Stone Disease
- •Ultrasound
- •Plain Radiographs and IVU
- •Renal Cystic Disease
- •Benign Renal Cysts
- •Hereditary Renal Cystic Disease
- •Complex Renal Cysts
- •Renal Trauma
- •References
- •Introduction
- •Pathophysiology
- •Susceptibility and Resistance
- •Epidemiological Breakpoints
- •Clinical Breakpoints
- •Pharmacodynamic Parameters
- •Pharmacokinetic Parameters
- •Fosfomycin
- •Nitrofurantoin
- •Pivmecillinam
- •b-Lactam-Antibiotics
- •Penicillins
- •Cephalosporins
- •Carbapenems
- •Aminoglycosides
- •Fluoroquinolones
- •Trimethoprim, Cotrimoxazole
- •Glycopeptides
- •Linezolid
- •Conclusion
- •References
- •7: An Overview of Renal Physiology
- •Introduction
- •Body Fluid Compartments
- •Regulation of Potassium Balance
- •Regulation of Acid–Base Balance
- •Diuretics
- •Suggested Reading
- •8: Ureteral Physiology and Pharmacology
- •Ureteral Anatomy
- •Modulation of Peristalsis
- •Ureteral Pharmacology
- •Conclusion
- •References
- •Introduction
- •Afferent Signaling Pathways
- •Efferent Signaling
- •Parasympathetic Nerves
- •Sympathetic Nerves
- •Vesico-Spinal-Vesical Micturition Reflex
- •Peripheral Targets
- •Afferent Signaling Mechanisms
- •Urothelium
- •Myocytes
- •Cholinergic Receptors
- •Muscarinic Receptors
- •Nicotinic Receptors
- •Adrenergic Receptors (ARs)
- •a-Adrenoceptors
- •b-Adrenoceptors
- •Transient Receptor Potential (TRP) Receptors
- •Phosphodiesterases (PDEs)
- •CNS Targets
- •Opioid Receptors
- •Serotonin (5-HT) Mechanisms
- •g-Amino Butyric Acid (GABA) Mechanisms
- •Gabapentin
- •Neurokinin and Neurokinin Receptors
- •Summary
- •References
- •10: Pharmacology of Sexual Function
- •Introduction
- •Sexual Desire/Arousal
- •Endocrinology
- •Steroids in the Male
- •Steroids in the Female
- •Neurohormones
- •Neurotransmitters
- •Dopamine
- •Serotonin
- •Pharmacological Strategies
- •CNS Drugs
- •Enzyme-inducing Antiepileptic Drugs
- •Erectile Function
- •Ejaculatory Function
- •Premature Ejaculation
- •Abnormal Ejaculation
- •Conclusions
- •References
- •Epidemiology
- •Calcium-Based Urolithiasis
- •Uric Acid Urolithiasis
- •Infectious Urolithiasis
- •Cystine-Based Urolithiasis
- •Aims
- •Who Deserves Metabolic Evaluation?
- •Metabolic Workup for Stone Producers
- •Medical History and Physical Examination
- •Stone Analysis
- •Serum Chemistry
- •Urine Evaluation
- •Urine Cultures
- •Urinalysis
- •Twenty-Four Hour Urine Collections
- •Radiologic Imaging
- •Medical Management
- •Conservative Management
- •Increased Fluid Intake
- •Citrus Juices
- •Dietary Restrictions
- •Restricted Oxalate Diet
- •Conservative Measures
- •Selective Medical Therapy
- •Absorptive Hypercalciuria
- •Thiazide
- •Orthophosphate
- •Renal Hypercalciuria
- •Primary Hyperparathyroidism
- •Hyperuricosuric Calcium Oxalate Nephrolithiasis
- •Enteric Hyperoxaluria
- •Hypocitraturic Calcium Oxalate Nephrolithiasis
- •Distal Renal Tubular Acidosis
- •Chronic Diarrheal States
- •Thiazide-Induced Hypocitraturia
- •Idiopathic Hypocitraturic Calcium Oxalate Nephrolithiasis
- •Hypomagnesiuric Calcium Nephrolithiasis
- •Gouty Diathesis
- •Cystinuria
- •Infection Lithiasis
- •Summary
- •References
- •12: Molecular Biology for Urologists
- •Introduction
- •Inherited Changes in Cancer Cells
- •VEGR and Cell Signaling
- •Targeting mTOR
- •Conclusion
- •References
- •13: Chemotherapeutic Agents for Urologic Oncology
- •Introduction
- •Bladder Cancer
- •Muscle Invasive Bladder Cancer
- •Metastatic Bladder Cancer
- •Conclusion
- •Prostate Cancer
- •Other Chemotherapeutic Drugs or Combinations for Treating HRPC
- •Conclusion
- •Renal Cell Carcinoma
- •Chemotherapy
- •Immunotherapy
- •Angiogenesis Inhibitor Drugs
- •Conclusion
- •Testicular Cancer
- •Stage I Seminoma
- •Stage I non-seminomatous Germ Cell Tumours (NSGCT)
- •Metastatic Germ Cell Tumours
- •Low-Volume Metastatic Disease (Stage II A/B)
- •Advanced Metastatic Disease
- •Salvage Chemotherapy for Relapsed or Refractory Disease
- •Conclusion
- •Penile Cancer
- •Side Effects of Chemotherapy
- •Conclusion
- •References
- •14: Tumor and Transplant Immunology
- •Antibodies
- •Cytotoxic and T-helper Cells
- •Immunosuppression
- •Induction Therapy
- •Maintenance Therapy
- •Rejection
- •Posttransplant Lymphoproliferative Disease
- •Summary
- •References
- •15: Pathophysiology of Renal Obstruction
- •Causes of Renal Obstruction
- •Effects on Prenatal Development
- •Prenatal Hydronephrosis
- •Spectrum of Renal Abnormalities
- •Renal Functional Changes
- •Renal Growth/Counterbalance
- •Vascular Changes
- •Inflammatory Mediators
- •Glomerular Development Changes
- •Mechanical Stretch of Renal Tubules
- •Unilateral Versus Bilateral
- •Limitations of Animal Models
- •Future Research
- •Issues in Patient Management
- •Diagnostic Imaging
- •Ultrasound
- •Intravenous Urography
- •Antegrade Urography and the Whitaker Test
- •Nuclear Renography
- •Computed Tomography
- •Magnetic Resonance Urography
- •Hypertension
- •Postobstructive Diuresis
- •References
- •Introduction
- •The Normal Lower Urinary Tract
- •Anatomy
- •Storage Function
- •Voiding Function
- •Neural Control
- •Symptoms
- •Flow Rate and Post-void Residual
- •Voiding Cystometry
- •Male
- •Female
- •Neurourology
- •Conclusions
- •References
- •17: Urologic Endocrinology
- •The Testis
- •Normal Androgen Metabolism
- •Epidemiological Aspects
- •Prostate
- •Brain
- •Muscle Mass and Adipose Tissue
- •Bones
- •Ematopoiesis
- •Metabolism
- •Cardiovascular System
- •Clinical Assessment
- •Biochemical Assessment
- •Treatment Modalities
- •Oral Preparations
- •Parenteral Preparations
- •Transdermal Preparations
- •Side Effects and Treatment Monitoring
- •Body Composition
- •Cognitive Decline
- •Bone Metabolism
- •The Kidneys
- •Endocrine Functions of the Kidney
- •Erythropoietin
- •Calcitriol
- •Renin
- •Paraneoplastic Syndromes
- •Hypercalcemia
- •Hypertension
- •Polycythemia
- •Other Endocrine Abnormalities
- •References
- •General Physiology
- •Prostate Innervation
- •Summary
- •References
- •Wound Healing
- •Inflammation
- •Proliferation
- •Remodeling
- •Principles of Plastic Surgery
- •Tissue Characteristics
- •Grafts
- •Flap
- •References
- •Lower Urinary Tract Symptoms
- •Storage Phase
- •Voiding Phase
- •Return to Storage Phase
- •Urodynamic Parameters
- •Urodynamic Techniques
- •Volume Voided Charts
- •Pad Testing
- •Typical Test Schedule
- •Uroflowmetry
- •Post Voiding Residual
- •Further Diagnostic Evaluation of Patients
- •Cystometry with or Without Video
- •Cystometry
- •Videocystometrography (Cystometry + Cystourethrography)
- •Cystometric Findings
- •Comment:
- •Measurements During the Storage Phase:
- •Measurements During the Voiding Phase:
- •Abnormal Function
- •Disorders of Sensation
- •Causes of Hypersensitive Bladder Sensation
- •Causes of Hyposensitive Bladder Sensation
- •Disorders of Detrusor Motor Function
- •Bladder Outflow Tract Dysfunction
- •Detrusor–Urethral Dyssynergia
- •Detrusor–Bladder Neck Dyssynergia
- •Detrusor–Sphincter Dyssynergia
- •Complex Urodynamic Investigation
- •Urethral Pressure Measurement
- •Technique
- •Neurophysiological Evaluation
- •Conclusion
- •References
- •Endoscopy
- •Cystourethroscopy
- •Ureteroscopy and Ureteropyeloscopy
- •Nephroscopy
- •Virtual Reality Simulators
- •Lasers
- •Clinical Application of Lasers
- •Condylomata Acuminata
- •Urolithiasis
- •Benign Prostatic Hyperplasia
- •Ureteral and Urethral Strictures
- •Conclusion
- •References
- •Introduction
- •The Prostatitis Syndromes
- •The Scope of the Problem
- •Category III CP/CPPS
- •The Goal of Treatment
- •Conservative Management
- •Drug Therapy
- •Antibiotics
- •Anti-inflammatories
- •Alpha blockers
- •Hormone Therapies
- •Phytotherapies
- •Analgesics, muscle relaxants and neuromodulators
- •Surgery
- •A Practical Management Plan
- •References
- •Orchitis
- •Definition and Etiology
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation
- •Treatment of Infectious Orchitis
- •Epididymitis
- •Definition and Etiology
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation of Epididymitis
- •Treatment of Acute Epididymitis
- •Treatment of Chronic Epididymitis
- •Treatment of Spermatic Cord Torsion
- •Fournier’s Gangrene
- •Definition and Etiology
- •Risk Factors
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation
- •Treatment
- •References
- •Fungal Infections
- •Candidiasis
- •Aspergillosis
- •Cryptococcosis
- •Blastomycosis
- •Coccidioidomycosis
- •Histoplasmosis
- •Radiographic Findings
- •Treatment
- •Tuberculosis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Schistosomiasis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Filariasis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Onchocerciasis
- •References
- •25: Sexually Transmitted Infections
- •Introduction
- •STIs Associated with Genital Ulcers
- •Herpes Simplex Virus
- •Diagnosis
- •Treatment
- •Chancroid
- •Diagnosis
- •Treatment
- •Syphilis
- •Diagnosis
- •Treatment
- •Lymphogranuloma Venereum
- •Diagnosis
- •Treatment
- •Chlamydia
- •Diagnosis
- •Treatment
- •Gonorrhea
- •Diagnosis
- •Treatment
- •Trichomoniasis
- •Diagnosis
- •Treatment
- •Human Papilloma Virus
- •Diagnosis
- •Treatment
- •Scabies
- •Diagnosis
- •Treatment
- •References
- •26: Hematuria: Evaluation and Management
- •Introduction
- •Classification of Hematuria
- •Macroscopic Hematuria
- •Microscopic Hematuria
- •Dipstick Hematuria
- •Pseudohematuria
- •Factitious Hematuria
- •Menstruation
- •Aetiology
- •Malignancy
- •Urinary Calculi
- •Infection and Inflammation
- •Benign Prostatic Hyperplasia
- •Trauma
- •Drugs
- •Nephrological Causes
- •Assessment
- •History
- •Examination
- •Investigations
- •Dipstick Urinalysis
- •Cytology
- •Molecular Tests
- •Blood Tests
- •Flexible Cystoscopy
- •Upper Urinary Tract Evaluation
- •Renal USS
- •KUB Abdominal X-Ray
- •Intravenous Urography (IVU)
- •Computed Tomography (CT)
- •Retrograde Urogram Studies
- •Magnetic Resonance Imaging (MRI)
- •Additional Tests and Renal Biopsy
- •Intractable Hematuria
- •Loin Pain Hematuria Syndrome
- •References
- •27: Benign Prostatic Hyperplasia (BPH)
- •Historical Background
- •Pathophysiology
- •Patient Assessment
- •Treatment of BPH
- •Watchful Waiting
- •Drug Therapy
- •Interventional Therapies
- •Conclusions
- •References
- •28: Practical Guidelines for the Treatment of Erectile Dysfunction and Peyronie´s Disease
- •Erectile Dysfunction
- •Introduction
- •Diagnosis
- •Basic Evaluation
- •Cardiovascular System and Sexual Activity
- •Optional Tests
- •Treatment
- •Medical Treatment
- •Oral Agents
- •Phosphodiesterase Type 5 (PDE 5) Inhibitors
- •Nonresponders to PDE5 Inhibitors
- •Apomorphine SL
- •Yohimbine
- •Intracavernosal and Intraurethral Therapy
- •Intracavernosal Injection (ICI) Therapy
- •Intraurethral Therapy
- •Vacuum Constriction Devices
- •Surgical Therapy
- •Conclusion
- •Peyronie´s Disease (PD)
- •Introduction
- •Oral Drug Therapy
- •Intralesional Drug Therapy
- •Iontophoresis
- •Radiation Therapy
- •Surgical Therapy
- •References
- •29: Premature Ejaculation
- •Introduction
- •Epidemiology
- •Defining Premature Ejaculation
- •Voluntary Control
- •Sexual Satisfaction
- •Distress
- •Psychosexual Counseling
- •Pharmacological Treatment
- •On-Demand Treatment with Tramadol
- •Topical Anesthetics
- •Phosphodiesterase Inhibitors
- •Surgery
- •Conclusion
- •References
- •30: The Role of Interventional Management for Urinary Tract Calculi
- •Contraindications to ESWL
- •Complications of ESWL
- •PCNL Access
- •Instrumentation for PCNL
- •Nephrostomy Drains Post PCNL
- •Contraindications to PCNL
- •Complications of PCNL
- •Semirigid Ureteroscopy
- •Flexible Ureteroscopy
- •Electrohydraulic Lithotripsy (EHL)
- •Ultrasound
- •Ballistic Lithotripsy
- •Laser Lithotripsy
- •Ureteric Stents
- •Staghorn Calculi
- •Lower Pole Stones
- •Horseshoe Kidneys and Stones
- •Calyceal Diverticula Stones
- •Stones and PUJ Obstruction
- •Treatment of Ureteric Colic
- •Medical Expulsive Therapy (MET)
- •Intervention for Ureteric Stones
- •Stones in Pregnancy
- •Morbid Obesity
- •References
- •Anatomy and Function
- •Pathophysiology
- •Management
- •Optical Urethrotomy/Dilatation
- •Urethral Stents
- •Preoperative Assessment
- •Urethroplasty
- •Anastomotic Urethroplasty
- •Substitution Urethroplasty
- •Grafts Versus Flaps
- •Oral Mucosal Grafts
- •Tissue Engineering
- •Graft Position
- •Conclusion
- •References
- •32: Urinary Incontinence
- •Epidemiology and Risk Factors
- •Pathophysiology
- •Urge Incontinence
- •Conservative Treatments
- •Pharmacotherapy
- •Invasive/ Surgical Therapies
- •Stress Urinary Incontinence
- •Male SUI Therapies
- •Female SUI Therapies
- •Mixed Urinary Incontinence
- •Conclusions
- •References
- •33: Neurogenic Bladder
- •Introduction
- •Examination and Diagnostic Tests
- •History and Physical Examination
- •Imaging
- •Urodynamics (UDS)
- •Evoked Potentials
- •Classifications
- •Somatic Pathways
- •Brain Lesions
- •Cerebrovascular Accident (CVA)
- •Parkinson’s Disease (PD)
- •Multiple Sclerosis
- •Huntington’s Disease
- •Dementias
- •Normal Pressure Hydrocephalus (NPH)
- •Tumors
- •Psychiatric Disorders
- •Spinal Lesions and Pathology
- •Intervertebral Disk Prolapse
- •Spinal Cord Injury (SCI)
- •Transverse Myelitis
- •Peripheral Neuropathies
- •Metabolic Neuropathies
- •Pelvic Surgery
- •Treatment
- •Summary
- •References
- •34: Pelvic Prolapse
- •Introduction
- •Epidemiology
- •Anatomy and Pathophysiology
- •Evaluation and Diagnosis
- •Outcome Measures
- •Imaging
- •Urodynamics
- •Indications for Management
- •Biosynthetics
- •Surgical Management
- •Anterior Compartment Repair
- •Uterine/Apical Prolapse
- •Enterocele Repair
- •Conclusion
- •References
- •35: Urinary Tract Fistula
- •Introduction
- •Urogynecologic Fistula
- •Vesicovaginal Fistula
- •Etiology and Risk Factors
- •Clinical Factors
- •Evaluation and Diagnosis
- •Pelvic Examination
- •Cystoscopy
- •Imaging
- •Treatment
- •Conservative Management
- •Surgical Management
- •Urethrovaginal Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Ureterovaginal Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Vesicouterine Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Uro-Enteric Fistula
- •Vesicoenteric Fistula
- •Pyeloenteric Fistula
- •Urethrorectal Fistula
- •References
- •36: Urologic Trauma
- •Introduction
- •Kidney
- •Expectant Management
- •Endovascular Therapy
- •Operative Intervention
- •Operative Management: Follow-up
- •Reno-Vascular Injuries
- •Pediatric Renal Injuries
- •Adrenal
- •Ureter
- •Diagnosis
- •Treatment
- •Delayed Diagnosis
- •Bladder and Posterior Urethra
- •Bladder Injuries: Initial Management
- •Bladder Injuries: Formal Repair
- •Anterior Urethral Trauma
- •Fractured Penis
- •Penile Amputation
- •Scrotal and Testicular Trauma
- •Imaging
- •CT-IVP (CT with Delayed Images)
- •Technique
- •Cystogram
- •Technique
- •Retrograde Urethrogram (RUG)
- •Technique
- •Retrograde Pyelogram (RPG)
- •Technique
- •One-Shot IVP
- •Technique
- •References
- •37: Bladder Cancer
- •Who Should Be Investigated?
- •Epidemiology
- •Risk Factors
- •Role of Screening
- •Signs and Symptoms
- •Imaging
- •Cystoscopy
- •Urine Tests
- •PDD-Assisted TUR
- •Pathology
- •NMIBC and Risk Groups
- •Intravesical Chemotherapy
- •Intravesical Immunotherapy
- •Immediate Cystectomy and CIS
- •Radical Cystectomy with Pelvic Lymph Node Dissection
- •sexual function-preserving techniques
- •Bladder-Preservation Treatments
- •Neoadjuvant Chemotherapy
- •Adjuvant Chemotherapy
- •Preoperative Radiotherapy
- •Follow-up After TUR in NMIBC
- •References
- •38: Prostate Cancer
- •Introduction
- •Epidemiology
- •Race
- •Geographic Variation
- •Risk Factors and Prevention
- •Family History
- •Diet and Lifestyle
- •Prevention
- •Screening and Diagnosis
- •Current Screening Recommendations
- •Biopsy
- •Pathology
- •Prognosis
- •Treatment of Prostate Cancer
- •Treatment for Localized Prostate Cancer (T1, T2)
- •Radical Prostatectomy
- •EBRT
- •IMRT
- •Brachytherapy
- •Treatment for Locally Advanced Prostate Cancer (T3, T4)
- •EBRT with ADT
- •Radical Prostatectomy
- •Androgen-Deprivation Therapy
- •Summary
- •References
- •39: The Management of Testis Cancer
- •Presentation and Diagnosis
- •Serum Tumor Markers
- •Primary Surgery
- •Testis Preserving Surgery
- •Risk Stratification
- •Surveillance Versus Primary RPLND
- •Primary RPLND
- •Adjuvant Treatment for High Risk
- •Clinical Stage 1 Seminoma
- •Risk-Stratified Adjuvant Treatment
- •Adjuvant Radiotherapy
- •Adjuvant Low Dose Chemotherapy
- •Primary Combination Chemotherapy
- •Late Toxicity
- •Salvage Strategies
- •Conclusion
- •References
- •Index
|
|
310 |
|
|
|
|
|
|
|
Practical Urology: EssEntial PrinciPlEs and PracticE |
|
Diagnostic Evaluation |
severe bacterial orchitis should be admitted |
||
|
|
and treated with intravenous antibiotics |
|
A thorough history and physical examination |
(aminoglycosides, cephalosporins, or combi- |
||
are the most valuable aspects of the diagnostic |
nations of both) until culture results are avail- |
||
evaluation of men with acute scrotal pain and |
able and sensitivity-specific adjustments can |
||
swelling. In patients with clinical orchitis, scro- |
be made.1 |
||
tal ultrasound should be obtained as testicular |
|
||
malignancy has been reported to masquerade |
Treatment of Noninfectious |
||
as orchitis.13 At least 10% of men with testicular |
|||
malignancy will initially be incorrectly diag- |
Epididymorchitis |
||
nosed as an acute inflammatory processes or |
Nonspecific therapy for patients with noninfec- |
||
spermatic cord torsion.14 High-frequency trans- |
|||
ducer sonography (7.5–10 MHz) is considered |
tious epididymorchitis includes nerve blocks, |
||
the best modality for evaluation of scrotal |
analgesics, scrotal elevation, bed rest, and non- |
||
pathology including orchitis.5 Heterogeneous |
steroidal anti-inflammatory drugs.18 |
||
echotexture and enlargement of the testicle are |
|
||
typical ultrasound findings in orchitis.15 Color |
Epididymitis |
||
Doppler ultrasound will show increased blood |
|||
flow to the epididymis in epididymorchitis16 |
Definition and Etiology |
||
(Fig. 23.1). Scrotal wall thickening, hydrocele, or |
|||
pyocele may also be seen in association with this |
|
||
inflammatory process on sonographic exams.17 |
Epididymitis is defined as inflammation of the |
||
|
|
epididymis.1 Epididymitis is the fifth most com- |
|
Treatment of Infectious Orchitis |
mon urologic diagnosis made in men between the |
||
ages of 18 and 59.19 In the US military, epididymi- |
|||
Doxycycline is effective in treating orchitis due |
tis is responsible for more man hours lost to ill- |
||
ness than any other urologic diagnosis.20 |
|||
to C. trachomatis or N. gonorrhea. Third- |
|||
There are a number of causes of this inflam- |
|||
generation cephalosporins, such as ceftriax- |
|||
matory process including bacterial, viral, and |
|||
one, are also effective antimicrobial agents for |
|||
fungal infections; autoimmune disease; trauma; |
|||
epididymorchitis. C. trachomatis is also effec- |
|||
vasculitis; and idiopathic inflammatory causes. |
|||
tively treated with quinolones and macrolides, |
|||
Although it is known that a great number of |
|||
and treatment is usually maintained for |
|||
patients with epididymitis do not have an |
|||
3 weeks. Evaluation and treatment of sexual |
|||
infectious source, there is a paucity of evidence |
|||
partners is recommended as well. Patients with |
|||
explaining the mechanism of this disease |
|||
|
|
||
|
|
process.18,21 |
|
|
|
Although the pathophysiology of acute |
|
|
|
epididymitis is not well understood, it is theo- |
|
|
|
rized to be secondary to retrograde flow of |
|
|
|
infected urine into the ejaculatory duct. This |
|
|
|
theory is supported by the fact that 56% of men |
|
|
|
diagnosed with acute bacterial epididymitis |
|
|
|
have concomitant benign prostatic hyperplasia |
|
|
|
with bladder outlet obstruction, urethral stric- |
|
|
|
ture disease, or prostate cancer. Other mecha- |
|
|
|
nisms must also be responsible for acute |
|
|
|
epididymitis as men who have undergone |
|
|
|
vasectomy develop symptoms of clinical |
|
|
|
epididymitis.18,21 |
|
|
|
E. coli is the most common infectious patho- |
|
|
|
gen in men older than 35 years of age with infec- |
|
|
|
tious epididymitis. Other bacterial pathogens |
|
Figure 23.1. Ultrasound image of acute epididymorchitis. |
less commonly seen include U. urealyticum, |
311
disordErs of scrotal contEnts
Corynebacteria species, Mycoplasma species, |
Clinical Signs and Symptoms |
and M. polymorpha.22 C. trachomatis is thought |
|
to be the primary source of infectious epididym- |
The mean age of patients presenting with |
itis in men 35 years of age or younger. Men |
epididymitis is 41. 43% of patients with |
infected with C. trachomatis have a 4.28% inci- |
epididymitis are between the ages of 20 and |
dence of developing acute epididymitis.23 |
39 years. Another 29% are between the ages of |
Chronic epididymitis has become the termi- |
40 and 59 years.36 |
nology of choice for urologists defining a clini- |
Acute epididymitis typically develops over a |
cal picture of chronic epididymal pain which |
course of several days and may present with |
may or may not be associated with clinical signs. |
pain and swelling, often unilateral. Fevers, ery- |
The discomfort may vary in degree and is asso- |
thema of the scrotum, hydrocele formation, ure- |
ciated with scrotal, epididymal, or testicular |
thritis, involvement of the testis, leukocytosis, |
pain lasting for at least 3 months.24 Chronic |
and positive urine cultures may also be seen in |
epididymitis is thought to account for up to 80% |
the presentation of acute epididymitis.18 Patients |
of visits to the urologist for scrotal pain.25 |
who undergo urinary tract instrumentation or |
Other less common causes of infectious |
even clean intermittent catheterization are at |
orchitis and epididymitis include B. melitensis, |
higher risk of developing infectious epididymi- |
M. tuberculosis, C. neoformans, and the mumps |
tis, especially if they have infected urine during |
virus.5 Chronic infectious epididymitis is most |
the time of instrumentation.36-38 |
commonly due to M. tuberculosis, which is |
Patients with chronic epididymitis can have |
thought to be secondary to hematogenous |
painful point tenderness in the epididymis with |
spread.26 Tenpercentof patientswithBrucellosis |
or without a palpable abnormality on physical |
develop epididymitis due to this gram negative |
examination. Scrotal ultrasound may demon- |
coccobacillus.27 |
strate an epididymal abnormality in these men. |
Other noninfectious sources of chronic |
It is also common that the clinical and ultra- |
epididymitis include sarcoidosis and Behcet’s |
sound evaluation in men with chronic epididym- |
disease. Sarcoidosis is more commonly seen in |
itis is completely normal.39 The majority of |
black patients, and this chronic granulomatous |
patients with chronic epididymitis have had |
process can affect the genitourinary tract in up |
these symptoms for 5 years, and the average age |
to 5% of patients.28,29 Behcet’s disease is a mul- |
at the time of presentation is 49 years.24 These |
tiorgan vasculitic disease of an idiopathic |
men may complain of erectile dysfunction, neu- |
nature.30 |
rological diseases, and musculoskeletal com- |
Clinicians must also be aware of iatrogenic |
plaints.18 When compared to controls, men with |
sources of epididymitis. Clinical noninfectious |
chronic epididymitis have a greater number of |
epididymitis can be a complication of the use of |
sexual partners, a more frequent history of sex- |
the drug amiodarone for arrhythmias.14 This is |
ually transmitted disease, and have used sexu- |
due to anti-amiodarone HCL antibodies which |
ally transmitted disease protection less often.24 |
attack the epididymal lining. Clinical epididym- |
Patients with male factor infertility may reveal |
itis is seen in 11% of patients on high-dose ami- |
a history of chronic epididymitis which has been |
odarone.31 Prostate biopsy is another iatrogenic |
associated with oligoasthenospermia and alter- |
source of epididymitis. There is a 0.2% rate of |
ations in spermatozoa DNA integrity.40 |
epididymitis after transrectal ultrasound and |
Patients with sarcoid epididymitis have pro- |
biopsy of the prostate.32 |
gressive enlargement of the epididymis, which |
Epididymitis in children is often secondary to |
can be bilateral in up to 30% of these men. |
systemic viral infection, most commonly sec- |
Extragonadal sarcoidosis frequently precedes |
ondary to M. pneumoniae, enteroviruses, and |
the diagnosis of sarcoid epididymitis.29 Patients |
adenoviruses. Mumps epididymitis is rarely |
with epididymitis associated with Behcet’s dis- |
seen in the USA since an effective vaccine was |
ease may have tender genital ulcers, aphthous |
introduced in 1985.33,34 A vasculitic epididymi- |
ulcers, and uveitis.30 |
tis may also develop in children with Henoch- |
Children with epididymitis present with an |
Schonlein Purpura due to immunoglobulin |
acute scrotum, sonographic hyperemia on |
A complex deposition, causing small vessel |
Doppler, and any two of the following: leukocy- |
vasculitis.35 |
tosis, fever with a temperature greater than |
|
|
312 |
|
|
|
|
|
Practical Urology: EssEntial PrinciPlEs and PracticE |
38.5°C, positive urine culture, or pyuria greater |
with indwelling ureteral stents, recent anal inter- |
|
than ten leukocytes per high-power field.41 |
course, or recent urinary tract instrumentation |
|
Henoch-Schonlein Purpura epididymitis occurs |
should undergo urine culture. Patients with |
|
in children between the ages of 22 and 11 years. |
positive results on testing for C. trachomatis or |
|
It has been reported that between 22% and 38% |
N. gonorrhea should undergo testing for other |
|
of these boys will present with scrotal swelling |
sexual transmitted diseases, including HIV.18 Up |
|
along with palpable purpura,hematuria,abdom- |
to 90% of men in this age group with epididymi- |
|
inal pain, and joint pain.35 |
tis have no evidence of C. trachomatis on ure- |
|
|
|
thral swab polymerase chain reaction.43-46 |
Diagnostic Evaluation of Epididymitis |
Ultrasound is utilized primarily to evaluate |
|
|
|
the acute scrotum with the intent to rule out tes- |
Diagnostic evaluation should begin with a thor- |
ticular torsion and is not needed to make the |
|
ough history and physical examination.22 |
diagnosis of epididymitis or to direct therapy. |
|
Patients younger than 35 should undergo gram |
Only 69% of cases of epididymitis have the clas- |
|
stain of urethral exudates and if they have |
sic sonographic features associated with |
|
greater than five white blood cells per high- |
epididymitis. Ultrasound should be reserved for |
|
power field, a positive leukocyte esterase test, or |
patients without a clear diagnosis of epididymi- |
|
microscopic examination of first voided urine |
tis.47 In men with epididymitis, the epididymis |
|
sediment revealing ten or more white blood cells |
may appear hypoechoic, or can appear hyper- |
|
per high-power field, they should be treated |
echoic in the presence of epididymal hemor- |
|
empirically for N. gonorrhea and C. trachomatis. |
rhage. Scrotal wall thickening, hydrocele, or |
|
They should also undergo a culture of nucleic |
pyocele may also be seen in association with |
|
acid amplification test of a urethral swab or |
inflammatory epididymitis. Color Doppler may |
|
urine PCRs for N. gonorrhea and C. trachomatis. |
show increased blood flow to the epididymis in |
|
In patients older than 35 years of age, leukocyte |
epididymitis.17 |
|
esterase test or microscopic examination of first |
In sarcoid epididymitis, scrotal ultrasound |
|
voided urine sediment revealing ten or more |
may reveal an enlarged, heterogeneous |
|
white blood cells per high-power field should be |
epididymis,which may have distinct nodules.48,49 |
|
treated empirically for a bacterial source. They |
Sarcoid epididymitis can lead to azoospermia |
|
should also have cultures and gram stains of |
secondary to extrinsic compression of the |
|
voided urine obtained.42(see Table 23.1). |
epididymal ducts. Patients with the diagnosis of |
|
Children, adolescents who are not sexually |
sarcomatoid epididymitis interested in fertility |
|
active, and patients older than 35 years of age |
should have a semen analysis performed.50 |
|
should have midstream urine collected. Those |
Testicular torsion should be ruled out in patients |
|
with positive dipsticks or microscopic examina- |
with Henoch-Schonlein Purpura epididymitis |
|
tions should have urine sent for culture. Patients |
as they present with painful scrotal swelling.35 |
|
Table 23.1. centers for disease control’s 2006 guidelines for the diagnosis and management of epididymitis |
||
Age |
Younger than 35 |
Older than 35 |
lab tests |
gram stain of urethral exudate for urethritis (> 5 white |
|
blood cells/high-power field) or leukocyte esterase |
|
test or microscopic examination of first-void urine |
|
sediment demonstrating at or above10 WBc/hpf |
|
culture or nucleic acid amplification test of urethral |
|
swab (or urine) |
leukocyte esterase test or microscopic examination of first-void urine sediment demonstrating at or above10 WBc/hpf culture and gram stain of voided urine
treatment |
Empiric antibiotics to cover N gonorrhea and C. trachomatis |
|
aceftriaxone 250 mg intramuscularly x1 and |
|
doxycycline 100 mg po bid x10 days |
Empiric antibiotics to cover coliform bacteria levofloxacin 500 mg qd x10 days or ofloxacin 300 mg bid x10 days
aPatients younger than 35 with allergies to penicillins or tetracyclines should be treated with levofloxacin or ofloxacin.if N.gonorrhea is suspected, patients may need to be desensitized to penicillin on account of the high rate of fluoroquinolone resistance evolving in N gonorrhea.42
313
disordErs of scrotal contEnts
Children with acute epididymitis and a posi- |
injection therapy.24Despite evidence that up to |
|||||||
tive urine culture should undergo renal ultra- |
75% of patients do not have an identifiable bac- |
|||||||
sound and VCUG. Ultrasound examination of |
terial urinary tract infection concomitantly with |
|||||||
the kidneys and urinary bladder without VCUG |
their clinical epididymitis, antibiotics are rou- |
|||||||
is adequate for children with acute epididymitis |
tinely given. Empirical antibiotic administration |
|||||||
and a negative urine culture.41 |
in the absence of positive urine cultures has |
|||||||
|
been steadily increasing, from 75% to 95% |
|||||||
Treatment of Acute Epididymitis |
between the years of 1965 and 2005. Antibiotic |
|||||||
administration does not decrease the length of |
||||||||
|
||||||||
The evaluation and treatment of epididymitis |
symptoms or the return to full activity in men |
|||||||
without an identifiable bacterial pathogen.36,53 |
||||||||
traditionally includes use of empiric antibiotics |
||||||||
|
|
|
|
|
|
|
||
when infection is suspected and supportive |
|
|
|
|
|
|
|
|
management such as bed rest, scrotal elevation, |
Surgical Treatment of Chronic |
|
||||||
analgesics, and nonsteroidal anti-inflammatory |
Epididymitis |
|
|
|
|
|||
drugs. In patients at risk for a sexually transmit- |
|
|
|
|
||||
ted disease, treatment should consist of one dose |
Surgical treatment for chronic epididymitis is |
|||||||
of Ceftriaxone 250 mg intramuscularly and |
||||||||
poorly studied in clinical trials with no level- |
||||||||
Doxycycline 100 mg by mouth twice a day for |
||||||||
one evidence to support the use of a specific sur- |
||||||||
10 days. Patients older than 35 years of age with |
||||||||
gical procedure. Fewer than 250 patients with |
||||||||
a suspected bacterial pathogen should be treated |
||||||||
chronic scrotal pain have been treated with dif- |
||||||||
empirically with Levofloxacin 500 mg by mouth |
||||||||
fering surgical therapies in the available litera- |
||||||||
daily for 10 days or Ofloxacin 300 mg by mouth |
||||||||
ture |
despite the common |
nature of |
chronic |
|||||
twice a day for 10 days.42 |
||||||||
scrotal pain. The authors |
do |
not |
advocate |
|||||
In patients diagnosed with C. trachomatis, |
||||||||
orchiectomy for chronic orchitis/epididymitis, |
||||||||
sexual partners should be treated as well to pre- |
||||||||
but if orchiectomy is recommended, the patient |
||||||||
vent pelvic inflammatory disease, infertility, and |
||||||||
should previously have failed conservative ther- |
||||||||
chronic pelvic pain in the female partner. |
||||||||
apy and must be apprised of the risks, benefits, |
||||||||
Without treatment of the partner, the couple |
||||||||
and options of orchiectomy. As many patients |
||||||||
will be at risk of transmitting the pathogen back |
||||||||
will continue to have pain or have pain recur |
||||||||
and forth to one another and causing recurrent |
||||||||
after orchiectomy, the surgeon should be aware |
||||||||
infections.51 |
||||||||
of the medical legal aspects of this action. |
||||||||
If the patient appears toxic, has systemic |
||||||||
In |
one |
study, 10 |
patients |
with |
chronic |
|||
symptoms (fevers or leukocytosis, necrotizing |
||||||||
epididymitis (defined as epididymal pain last- |
||||||||
fasciitis or testicular infarction), or has signifi- |
||||||||
ing greater than 3 months),underwent epididy- |
||||||||
cant comorbidities (e.g. immunosuppression or |
||||||||
mectomy for intractable symptoms. Only one of |
||||||||
uncontrolled diabetes mellitus), then hospital- |
||||||||
these patients had significant improvement in |
||||||||
ization is warranted where close observation, |
||||||||
pain.54 Other authors have reported much higher |
||||||||
supportive care, parenteral antibiotics, and |
success rates, such as six out of seven patients |
|||||||
fluid resuscitation should be administered as |
||||||||
(86%) having significant improvement in pain |
||||||||
needed.18 |
||||||||
|
|
|
55 |
|
|
|
||
|
after epididymectomy. Chronic or recurrent |
|||||||
|
epididymitis and persistent epididymalgia with |
|||||||
Treatment of Chronic Epididymitis |
point tenderness to the epididymis may be rea- |
|||||||
|
sonable indications for epididymectomy.56 |
|||||||
Although there is no level-one evidence for the |
Surgical treatment for chronic epididymitis |
|||||||
optimal treatment of chronic epididymitis, local |
should be considered only after failure of exten- |
|||||||
supportive therapy including heat, nerve blocks, |
sive conservative therapy and after appropriate |
|||||||
analgesics, tricyclic antidepressants, anticonvul- |
counseling, with the understanding that the |
|||||||
sants such as gabapentin,and anti-inflammatory |
symptoms may not improve after surgery, or |
|||||||
drugs are common practice and may offer some |
may indeed worsen.A retrospective review of 32 |
|||||||
relief.52 Other treatment options implemented |
men who underwent epididymectomy for |
|||||||
for chronic epididymitis include phytotherapy, |
chronic epididymitis showed that outcomes |
|||||||
anxiolytics, narcotics, acupuncture, and steroid |
were |
best |
when the |
patient had a |
palpable |
|
|
314 |
|
|
|
|
|
|
|
Practical Urology: EssEntial PrinciPlEs and PracticE |
|
epididymal abnormality on physical examina- |
with doxycycline 100 mg by mouth twice a day |
||
tion.Men in this study without a palpable abnor- |
for 6 weeks and either streptomycin 1 g intra- |
||
mality, but with sonographic changes had |
muscularly daily for 14 days or rifampin 600– |
||
slightly worse outcomes, and those without |
900 mg daily by mouth for 6 weeks.62 |
||
either a palpable abnormality or a demonstrable |
Epididymitis in children is often secondary to |
||
ultrasound abnormality did not improve with |
viral infections and should be treated conserva- |
||
epididymectomy.39 |
tively with ice packs and analgesics.34 Epidi- |
||
Some surgeons have attempted microsurgical |
dymitis associated with Henoch-Schonlein |
||
denervation of the spermatic cord for symp- |
Purpura is a self-limited disease and may improve |
||
tomatic relief of chronic scrotal pain. Micro- |
with the administration of corticosteroids.35 |
||
surgical denervation of the spermatic cord was |
|
||
performed in 79 men on 95 testicular units for |
Testicular Torsion and Torsion |
||
chronic orchalgia over a mean duration of |
|||
62 months. There was complete relief of pain in |
of the Testicular and Epididymal |
||
71% of the patients, partial relief in 17%, and |
|||
Appendages |
|||
there was no change from the preoperative sta- |
|||
tus in 12%, with no patients experiencing wors- |
|
||
ened postoperative pain. The mean follow-up |
Clinical Signs, Symptoms, |
||
was 20.3 months.57 |
|||
|
|
and Differential Diagnosis of |
|
Treatment of Purulent and Atypical |
the Acute Scrotum |
||
The acute scrotum includes the diagnoses of |
|||
Epididymitis |
|||
|
|
testicular torsion, acute epididymorchitis, and |
|
The diagnosis of purulent epididymitis is made |
torsion of a testicular appendage. A thorough |
||
with the combination of physical examination, |
history and physical examination is the key to |
||
ultrasound evaluation, and occasionally needle |
making an accurate diagnosis. Leukocytosis is |
||
aspiration of the epididymis. Epididymectomy |
frequently not found to be a distinguishing |
||
is performed when possible and orchiectomy is |
parameter for these diagnoses.Pyuria was found |
||
performed when an abscess or necrosis of tes- |
in 26% of patients with epididymorchitis. Color |
||
ticular tissue is present. Common causative |
Doppler ultrasound has the highest sensitivity |
||
organisms include N. gonorrhea, C. trachomatis, |
(87.9%) and specificity (93.3%) of differentiat- |
||
and E. coli.58 |
ing testicular torsion from the other diagnoses |
||
Corticosteroids should be utilized as first-line |
of the acute scrotum.63 |
||
treatment for pain and swelling in sarcoid |
Testicular torsion can be seen in patients of |
||
epididymitis. In the rare case where surgical |
any age, but most commonly occurs in males |
||
exploration is undertaken, a frozen section |
between the ages of 12 and 18. Testicular torsion |
||
should be obtained to prevent an unnecessary |
occurs in one out of every 4,000 men below the |
||
epididymectomy or orchiectomy.29 If a patient |
age of 25.64 The risk of having spermatic cord |
||
with sarcoid epididymitis is found to be oli- |
torsion or torsion of an appendage of the testicle |
||
gospermic, he should consider sperm storage.59 |
or epididymis is one in 160 by the age of 25.65 |
||
Treatment of Behcet’s disease is targeted at |
The incidence of bilateral testicular torsion |
||
symptomatic relief, mainly with corticosteroids.30 |
(synchronous or metachronous) is 2%.66 |
||
Treatment of epididymal tuberculosis should |
The most consistent presentation of testicular |
||
consist of a 6 month course using a three drug |
torsion is the acute onset of severe testicular |
||
regimen including isoniazid,rifampin,and pyrazi- |
pain. Pain may be followed by nausea, vomiting, |
||
namide. Ethambutol should be added to the regi- |
and even a low-grade fever. The hemiscrotum of |
||
men if the patient is from a highly drug-resistant |
the affected side is typically swollen, tender, and |
||
region, until sensitivities are available.60,61 Men |
inflamed on physical examination.Another typi- |
||
with Bacille Calmette-Guerin epididymitis are |
cal physical sign is the absence of the cremasteric |
||
treated with isoniazid and rifampin. |
reflex.67 Pain is not relieved by elevation of |
||
Patients with epididymitis due to Brucellosis, |
the scrotum.11 Patients may present with a “bell |
||
(infection with B. melitensis), should be treated |
clapper” deformity, when the tunica vaginalis |
315
disordErs of scrotal contEnts
Tunica vaginalis
Epididymis
Testis
Scrotum
Figure 23.2. Bell clapper deformity.
completely encircles the distal spermatic cord, epididymis, and the testis; instead of attaching to the posterolateral aspect of the testis (Fig. 23.2). This resembles the clapper of a bell,as the testicle is free to rotate and swing freely within the tunica vaginalis. Bell clapper deformities occur bilaterally in 80% of patients who present with testicular torsion.6,68 On physical examination, the torqued testicle is tender and high riding with a horizontal lie. Irreversible ischemia begins at 6 hours after torsion, or from the onset of symptoms depending on the variability in testicular blood flow following torsion.69 Torsion of the spermatic cord results in testicular ischemia by causing venous engorgement, edema, and hemorrhage which result in arterial compromise.70
Intermittent testicular torsion is episodic twisting of the spermatic cord with spontaneous resolution.71 Patients in the appropriate agegroup with acute scrotal pain and rapid resolution should be suspected of having intermittent testicular torsion, and should be treated with scheduled bilateral orchiopexy.72
Clinicians must also be aware of the possibility of testicular torsion in patients who have had prior orchiopexy, as such cases have rarely been reported.73
Extravaginal testicular torsion (occurring outside of the tunica vaginalis), when the testis and gubernaculum can rotate freely, occurs
Figure 23.3. Extravaginal torsion.
exclusively in newborns74 (Fig. 23.3). Neonates with extravaginal testicular torsion present clinically with scrotal swelling, discoloration, and a firm, painless mass in the scrotum.75 In these neonates, the testis is usually necrotic from infarction at the time of birth. The sonographic appearance demonstrates an enlarged heterogeneous testicle without color Doppler flow to the testis or spermatic cord, skin thickening, and an ipsilateral hydrocele.76 Neonatal testicular torsion is estimated to occur in one in 7,500 newborns.77 Complicated pregnancies and vaginal deliveries are associated with a higher risk for testicular torsion.78
Testicular torsion is also more common in a cryptorchid testis. 73% of cases of torsion in cryptorchid testes were reported on the left side. These patients presented with an empty hemiscrotum; a tender, firm mass in the groin; and inguinal swelling and erythema. Doppler ultrasound is useful to confirm the diagnosis. The rates of surgical testicular salvage in these patients are very poor due to delay in presentation, diagnosis, or referral to a urologist.79
The primary imaging modality of choice for assistance in evaluation of the acute scrotum is